NL-OMON26633招募中不适用
Insight into bladder cancer care
Dutch Cancer Society (KWF Kankerbestrijding)0 个研究点目标入组 6,500 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 6,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All newly diagnosed Dutch patients with High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIB; Cis and T1) and Muscle invasive Bladder Cancer (MIBC; =T2) between November 1st 2017 and end 2019 in the Netherlands.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLArothelial cancerCTIS2024-510865-41-00Aarhus Universitetshospital282
招募中
不适用
Prospective Bladder Cancer Infrastructure - An infrastructure for observational and interventional bladder cancer research10038364bladder cancerNL-OMON54621Stichting Prospectieve Blaaskanker Infrastructuur3,500
已完成
不适用
Assessment of the role of the Xpert Bladder Cancer detect assay in patients with asymptomatic hematuriaR31D41.4C67Unspecified haematuriaBladderMalignant neoplasm of bladderDRKS00027469Cepheid Europe SAS400
进行中（未招募）
不适用
rinary Xpert bladder cancer detection test in patients with haematuriaSuspected bladder cancerMalignant neoplasm of bladderCancerISRCTN40815027niversity of Dundee600
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220